West Pharmaceutical Services Stock Performance
| WST Stock | USD 208.95 8.27 3.81% |
West Pharmaceutical has a performance score of 2 on a scale of 0 to 100. The firm maintains a market beta of -0.12, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning West Pharmaceutical are expected to decrease at a much lower rate. During the bear market, West Pharmaceutical is likely to outperform the market. West Pharmaceutical right now maintains a risk of 2.53%. Please check out West Pharmaceutical sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to decide if West Pharmaceutical will be following its historical returns.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in West Pharmaceutical Services are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, West Pharmaceutical is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Actual Historical Performance (%)
One Day Return (0.82) | Five Day Return 1.86 | Year To Date Return (34.40) | Ten Year Return 293.98 | All Time Return 19.3 K |
Forward Dividend Yield 0.0039 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 0.84 | Dividend Date 2025-08-06 |
1 | Insider Trading | 02/28/2025 |
2 | Acquisition by Haugen Janet Brutschea of tradable shares of West Pharmaceutical subject to Rule 16b-3 | 03/31/2025 |
3 | Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. and Certain of Its Executives | 05/05/2025 |
| West Pharmaceutical dividend paid on 7th of May 2025 | 05/07/2025 |
4 | Securities Fraud Investigation Into West Pharmaceutical Services, Inc. ... | 05/08/2025 |
5 | Acquisition by Campbell Shane Alden of 1182 shares of West Pharmaceutical subject to Rule 16b-3 | 05/12/2025 |
6 | Glancy Prongay Murray LLP, a Leading Securities Fraud Law Firm Encourages West ... | 05/13/2025 |
7 | Law Offices of Frank R. Cruz Encourages West Pharmaceutical Services, Inc. Investors To Inquire About Securities Fraud Class Action | 05/14/2025 |
8 | Deadline Approaching West Pharmaceutical Services, Inc. Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith | 05/15/2025 |
9 | Deadline Alert West Pharmaceutical Services, Inc. ... | 05/16/2025 |
| Begin Period Cash Flow | 853.9 M |
West Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 20,345 in West Pharmaceutical Services on February 20, 2025 and sell it today you would earn a total of 550.00 from holding West Pharmaceutical Services or generate 2.7% return on investment over 90 days. West Pharmaceutical Services is generating 0.0734% of daily returns assuming volatility of 2.5334% on return distribution over 90 days investment horizon. In other words, 22% of stocks are less volatile than West, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
West Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for West Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as West Pharmaceutical Services, and traders can use it to determine the average amount a West Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.029
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | WST | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.53 actual daily | 22 78% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average West Pharmaceutical is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of West Pharmaceutical by adding it to a well-diversified portfolio.
West Pharmaceutical Fundamentals Growth
West Stock prices reflect investors' perceptions of the future prospects and financial health of West Pharmaceutical, and West Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on West Stock performance.
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.1 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 15.38 B | ||||
| Shares Outstanding | 71.85 M | ||||
| Price To Earning | 40.71 X | ||||
| Price To Book | 5.77 X | ||||
| Price To Sales | 5.34 X | ||||
| Revenue | 2.89 B | ||||
| Gross Profit | 1 B | ||||
| EBITDA | 743.8 M | ||||
| Net Income | 492.7 M | ||||
| Cash And Equivalents | 894.3 M | ||||
| Cash Per Share | 9.85 X | ||||
| Total Debt | 302.3 M | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 3.80 X | ||||
| Book Value Per Share | 37.37 X | ||||
| Cash Flow From Operations | 653.4 M | ||||
| Earnings Per Share | 6.38 X | ||||
| Market Capitalization | 15.48 B | ||||
| Total Asset | 3.64 B | ||||
| Retained Earnings | 3.96 B | ||||
| Working Capital | 987.7 M | ||||
| Current Asset | 673.7 M | ||||
| Current Liabilities | 314.3 M | ||||
About West Pharmaceutical Performance
Assessing West Pharmaceutical's fundamental ratios provides investors with valuable insights into West Pharmaceutical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the West Pharmaceutical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 72.63 | 52.04 | |
| Return On Tangible Assets | 0.14 | 0.15 | |
| Return On Capital Employed | 0.18 | 0.10 | |
| Return On Assets | 0.14 | 0.14 | |
| Return On Equity | 0.18 | 0.10 |
Things to note about West Pharmaceutical performance evaluation
Checking the ongoing alerts about West Pharmaceutical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for West Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 98.0% of the company outstanding shares are owned by institutional investors | |
| On 7th of May 2025 West Pharmaceutical paid $ 0.21 per share dividend to its current shareholders | |
| Latest headline from gurufocus.com: Deadline Alert West Pharmaceutical Services, Inc. ... |
- Analyzing West Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether West Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining West Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating West Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of West Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of West Pharmaceutical's stock. These opinions can provide insight into West Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for West Stock Analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.